One year on from the Pfizer vaccine: What stocks have fared the best and worst? By Investing.com – Investing.com UK

One year on from the Pfizer vaccine: What stocks have fared the best and worst? By Investing.com – Investing.com UK

By Samuel Indyk

Investing.com – It’s been almost a year since Pfizer (NYSE:) and BioNTech (NASDAQ:) announced positive data from their Phase 3 trial of their vaccine for COVID-19, paving the way for the economic recovery that has seen stocks across the globe reach record highs and surges in other assets such as cryptocurrencies, , base metals, and oil.

Analysts at AJ Bell have highlighted some winners (and losers) in the UK’s since the day Pfizer announced their positive data from the trial.